Skip to main content
Log in

Bone marrow aspirate concentrate injections provide similar results versus viscosupplementation up to 24 months of follow-up in patients with symptomatic knee osteoarthritis. A randomized controlled trial

  • KNEE
  • Published:
Knee Surgery, Sports Traumatology, Arthroscopy Aims and scope

Abstract

Purpose

The purpose of this double-blind randomized controlled trial (RCT) was to compare clinical improvement and radiographic findings up to 2 years of follow-up of a single intra-articular injection of bone marrow aspirate concentrate (BMAC) versus hyaluronic acid (HA) for the treatment of knee osteoarthritis (OA). The hypothesis was that BMAC injection could lead to better clinical and radiographic results compared to viscosupplementation.

Methods

Patients with bilateral knee OA were randomized to one intra-articular injection of tibial-derived BMAC in one knee and one HA injection in the contralateral knee. Sixty patients were enrolled, and 56 were studied up to the final follow-up (35 men, 21 women, mean age 57.8 ± 8.9 years), for a total of 112 knees. Patients were evaluated before the injection and at 1, 3, 6, 12, and 24 months with the IKDC subjective score, VAS for pain, and the KOOS score. Minimal clinically important difference (MCID), patient treatment judgement, and adverse events were documented, as well as bilateral X-Rays (Rosenberg view) before and after treatment.

Results

No severe adverse events nor differences were reported in terms of mild adverse events (7.1% vs 5.4%, p = ns) and treatment failures (10.7% vs 12.5%, p = ns) in BMAC and HA groups, respectively. The IKDC subjective score improved from baseline to all follow-ups for BMAC (p < 0.0005), while it improved up to 12 months (p < 0.0005) and then decreased at 24 months (p = 0.030) for HA. Compared to HA, BMAC showed a higher improvement for VAS pain at 12 (2.2 ± 2.6 vs 1.7 ± 2.5, p = 0.041) and 24 months (2.2 ± 2.6 vs 1.4 ± 2.8, p = 0.002). The analysis based on OA severity confirmed this difference only in Kellgren–Lawrence 1–2 knees, while comparable results were observed in moderate/severe OA. Radiographic evaluation did not show knee OA deterioration for both treatment groups, without intergroup differences.

Conclusion

BMAC did not demonstrate a clinically significant superiority at short-term compared to viscosupplementation, reporting overall comparable results in terms of clinical scores, failures, adverse events, radiographic evaluation, MCID achievement, and patient treatment judgment. However, while HA results decreased over time, BMAC presented more durable results in mild OA knees.

Level of evidence

Level I.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Altamura SA, Di Martino A, Andriolo L, Boffa A, Zaffagnini S, Cenacchi A et al (2020) Platelet-rich plasma for sport-active patients with knee osteoarthritis: limited return to sport. Biomed Res Int 2020:8243865

    Article  PubMed  PubMed Central  Google Scholar 

  2. Anz AW, Hubbard R, Rendos NK, Everts PA, Andrews JR, Hackel JG (2020) Bone marrow aspirate concentrate is equivalent to platelet-rich plasma for the treatment of knee osteoarthritis at 1 year: a prospective. Randomized trial. Orthop J Sports Med 8:2325967119900958

    PubMed  PubMed Central  Google Scholar 

  3. Baker N, Boyette LB, Tuan RS (2015) Characterization of bone marrow-derived mesenchymal stem cells in aging. Bone 70:37–47

    Article  CAS  PubMed  Google Scholar 

  4. Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SMA et al (2019) OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartilage 27:1578–1589

    Article  CAS  Google Scholar 

  5. Boffa A, Andriolo L, Franceschini M, Di Martino A, Asunis E, Grassi A, Zaffagnini S, Filardo G (2021) Minimal clinically important difference and patient acceptable symptom state in patients with knee osteoarthritis treated with PRP injection. Orthop J Sports Med 9(10):23259671211026242. ECollection 2021

  6. Boffa A, Salerno M, Merli G, De Girolamo L, Laver L, Magalon J, Sánchez M, Tischer T, Filardo G (2021) Platelet-rich plasma injections induce disease-modifying effects in the treatment of osteoarthritis in animal models. Knee Surg Sports Traumatol Arthrosc

  7. Bruyere O, Honvo G, Veronese N, Arden NK, Branco J, Curtis EM et al (2019) An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum 49:337–350

    Article  PubMed  Google Scholar 

  8. Caplan AI (2005) Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng 11:1198–1211

    Article  CAS  PubMed  Google Scholar 

  9. Cassano JM, Kennedy JG, Ross KA, Fraser EJ, Goodale MB, Fortier LA (2018) Bone marrow concentrate and platelet-rich plasma differ in cell distribution and interleukin 1 receptor antagonist protein concentration. Knee Surg Sports Traumatol Arthrosc 26:333–342

    Article  PubMed  Google Scholar 

  10. Cavallo C, Boffa A, Andriolo L, Silva S, Grigolo B, Zaffagnini S et al (2021) Bone marrow concentrate injections for the treatment of osteoarthritis: evidence from preclinical findings to the clinical application. Int Orthop 45:525–538

    Article  PubMed  Google Scholar 

  11. Chahla J, Cinque ME, Shon JM, Liechti DJ, Matheny LM, LaPrade RF et al (2016) Bone marrow aspirate concentrate for the treatment of osteochondral lesions of the talus: a systematic review of outcomes. J Exp Orthop 3:33

    Article  PubMed  PubMed Central  Google Scholar 

  12. Chen FH, Tuan RS (2008) Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther 10:223

    Article  PubMed  PubMed Central  Google Scholar 

  13. Davies BM, Snelling SJB, Quek L, Hakimi O, Ye H, Carr A et al (2017) Identifying the optimum source of mesenchymal stem cells for use in knee surgery. J Orthop Res 35:1868–1875

    Article  PubMed  Google Scholar 

  14. Di Martino A, Di Matteo B, Papio T, Tentoni F, Selleri F, Cenacchi A et al (2019) Platelet-rich plasma versus hyaluronic acid injections for the treatment of knee osteoarthritis: results at 5 years of a double-blind, randomized controlled trial. Am J Sports Med 47:347–354

    Article  PubMed  Google Scholar 

  15. Filardo G, Kon E, Longo UG, Madry H, Marchettini P, Marmotti A et al (2016) Non-surgical treatments for the management of early osteoarthritis. Knee Surg Sports Traumatol Arthrosc 24:1775–1785

    Article  PubMed  Google Scholar 

  16. Filardo G, Madry H, Jelic M, Roffi A, Cucchiarini M, Kon E (2013) Mesenchymal stem cells for the treatment of cartilage lesions: from preclinical findings to clinical application in orthopaedics. Knee Surg Sports Traumatol Arthrosc 21:1717–1729

    Article  PubMed  Google Scholar 

  17. Filardo G, Previtali D, Napoli F, Candrian C, Zaffagnini S, Grassi A (2020) PRP injections for the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials. Cartilage. https://doi.org/10.1177/19476035209311701947603520931170

    Article  PubMed  PubMed Central  Google Scholar 

  18. Fortier LA, Strauss EJ, Shepard DO, Becktell L, Kennedy JG (2019) Biological effects of bone marrow concentrate in knee pathologies. J Knee Surg 32:2–8

    Article  PubMed  Google Scholar 

  19. Hyer CF, Berlet GC, Bussewitz BW, Hankins T, Ziegler HL, Philbin TM (2013) Quantitative assessment of the yield of osteoblastic connective tissue progenitors in bone marrow aspirate from the iliac crest, tibia, and calcaneus. J Bone Joint Surg Am 95:1312–1316

    Article  PubMed  Google Scholar 

  20. Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J et al (2020) 2019 American College of Rheumatology/Arthritis Foundation Guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol 72:220–233

    Article  PubMed  Google Scholar 

  21. Kon E, Boffa A, Andriolo L, Di Martino A, Di Matteo B, Magarelli N et al (2021) Subchondral and intra-articular injections of bone marrow concentrate are a safe and effective treatment for knee osteoarthritis: a prospective, multi-center pilot study. Knee Surg Sports Traumatol Arthrosc https://doi.org/10.1007/s00167-021-06530-x

  22. Kon E, Filardo G, Drobnic M, Madry H, Jelic M, van Dijk N et al (2012) Non-surgical management of early knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc 20:436–449

    Article  PubMed  Google Scholar 

  23. Legre-Boyer V (2015) Viscosupplementation: techniques, indications, results. Orthop Traumatol Surg Res 101:S101-108

    Article  CAS  PubMed  Google Scholar 

  24. Mautner K, Bowers R, Easley K, Fausel Z, Robinson R (2019) Functional outcomes following microfragmented adipose tissue versus bone marrow aspirate concentrate injections for symptomatic knee osteoarthritis. Stem Cells Transl Med 8:1149–1156

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. McDaniel JS, Antebi B, Pilia M, Hurtgen BJ, Belenkiy S, Necsoiu C et al (2017) Quantitative assessment of optimal bone marrow site for the isolation of porcine mesenchymal stem cells. Stem Cells Int 2017:1836960

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ et al (2010) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 340:c869

    Article  PubMed  PubMed Central  Google Scholar 

  27. Narbona-Carceles J, Vaquero J, Suarez-Sancho S, Forriol F, Fernandez-Santos ME (2014) Bone marrow mesenchymal stem cell aspirates from alternative sources: is the knee as good as the iliac crest? Injury 45(Suppl 4):S42–S47

    Article  PubMed  Google Scholar 

  28. Olifirenko O, Savosko S, Movchan O (2020) Knee joint structural changes in osteoarthritis and injections of platelet rich plasma and bone marrow aspirate concentrate. Georgian Med News 184–188

  29. Petrella RJ (2005) Hyaluronic acid for the treatment of knee osteoarthritis: long-term outcomes from a naturalistic primary care experience. Am J Phys Med Rehabil 84:278–283; quiz 284, 293

  30. Previtali D, Merli G, Di Laura Frattura G, Candrian C, Zaffagnini S, Filardo G (2020) The long-lasting effects of “placebo injections” in knee osteoarthritis: a meta-analysis. Cartilage

  31. Riddle DL, Stratford PW (2013) Unilateral vs bilateral symptomatic knee osteoarthritis: associations between pain intensity and function. Rheumatology (Oxford) 52:2229–2237

    Article  Google Scholar 

  32. Schweinberger MH, Roukis TS (2007) Percutaneous autologous bone marrow harvest from the calcaneus and proximal tibia: surgical technique. J Foot Ankle Surg 46:411–414

    Article  PubMed  Google Scholar 

  33. Shapiro SA, Arthurs JR, Heckman MG, Bestic JM, Kazmerchak SE, Diehl NN et al (2019) Quantitative T2 MRI mapping and 12-month follow-up in a randomized, blinded, placebo controlled trial of bone marrow aspiration and concentration for osteoarthritis of the knees. Cartilage 10:432–443

    Article  CAS  PubMed  Google Scholar 

  34. Shapiro SA, Kazmerchak SE, Heckman MG, Zubair AC, O’Connor MI (2017) A prospective, single-blind, placebo-controlled trial of bone marrow aspirate concentrate for knee osteoarthritis. Am J Sports Med 45:82–90

    Article  PubMed  Google Scholar 

  35. Trigkilidas D, Anand A (2013) The effectiveness of hyaluronic acid intra-articular injections in managing osteoarthritic knee pain. Ann R Coll Surg Engl 95:545–551

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Turner L, Knoepfler P (2016) Selling stem cells in the USA: assessing the direct-to-consumer industry. Cell Stem Cell 19:154–157

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge Elettra Pignotti for the statistical analysis and Biologic Therapies for providing kits and centrifuge.

Funding

This study received no external funding.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization, S.Z. and G.F.; methodology, L.A. and E.K..; data curation, R.D.F.; writing—original draft preparation, A.B. and A.P..; writing—review and editing, G.F.; supervision, A.D.M., E.K., G.F., and S.Z. All authors have read and agreed to the published version of the manuscript.

Corresponding author

Correspondence to Alberto Poggi.

Ethics declarations

Conflict of interest

EK reports consulting for Carihealldt, Green Bone, Geistlich, and Bioveex, and speaking for Zimmer Biomet and Fidia Farmaceutici SPA. SZ reports non-financial support from personal fees from I + SRL, grants from Grants from FidiaFarmaceutici SPA, Cartihealltd, IGEA clinical biophysics, BIOMET, and Kensey Nash, outside the submitted work. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results. The other authors declare no conflict of interest.

Ethical approval

This prospective double-blind RCT was approved by the Hospital Ethics Committee of the Rizzoli Orthopaedic Institute, Bologna, Italy (prot. n. 0001181). The trial was registered at clinicaltrials.gov (registration number NCT03110679) and was entirely conducted in a highly specialized referral center for orthopaedic pathologies.

Informed consent

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Boffa, A., Di Martino, A., Andriolo, L. et al. Bone marrow aspirate concentrate injections provide similar results versus viscosupplementation up to 24 months of follow-up in patients with symptomatic knee osteoarthritis. A randomized controlled trial. Knee Surg Sports Traumatol Arthrosc 30, 3958–3967 (2022). https://doi.org/10.1007/s00167-021-06793-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00167-021-06793-4

Keywords

Navigation